Effect of atorvastatin on orthodontic tooth movement in male wistar rats (original) (raw)
Related papers
Effect of local administration of simvastatin on orthodontic tooth movement in rabbits
American Journal of Orthodontics and Dentofacial Orthopedics, 2019
Posttreatment relapse is a major challenging clinical issue. The objective of this study was to evaluate the effect of local administration of simvastatin on posttreatment relapse. Methods: Orthodontic tooth movement was induced in 10 white New Zealand rabbits. After 21 days of active tooth movement, the orthodontic appliances were removed, and the experimental teeth were allowed to relapse for 21 days. During the relapse phase, 1 mandibular quadrant received local simvastatin administration, and the other received the control vehicle solution on a weekly basis. Three-dimensional models of the experimental teeth were created to allow the measurement of experimental tooth movement and posttreatment relapse. The animals were killed at the end of the relapse phase for histomorphometric analysis of alveolar bone remodeling. Results: The mean relapse percentages were 75.83% in the quadrant receiving the control vehicle solution and 62.01% in the quadrant receiving simvastatin. Neither the relapse magnitude nor the relapse percentage showed a significant difference between the 2 quadrants. Histomorphometric analyses showed that local simvastatin administration yielded a significant reduction in the area of active bone-resorptive lacunae and a significant increase in newly formed bone area. Conclusions: Although local administration of simvastatin aids in bone remodeling associated with posttreatment relapse by reducing the area of active bone resorption and upregulating bone formation, it did not significantly minimize posttreatment relapse.
Use of Statins in Dental Implantology and Their Impact on Osseointegration: Animal Studies
IntechOpen eBooks, 2023
Statins are one of the most commonly used drugs for the prevention of atherosclerosis and ischemic heart disease. Statins have an antibacterial effect against oral pathogens, especially against Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis. Studies on animals that we analyzed in this chapter show that statins promote angiogenesis and osteoblast differentiation. Data on the effect of statins on the process of osseointegration are important in clinical practice and should be an integral part of dental education. PubMed, Cochrane Central, and Web of Science database search was performed for animal studies on statin effects on dental osseointegration. Fifteen studies performed on laboratory animals were identified where statins were applied systemically, locally, orally, subcutaneously, or intraosseously. Titan implants of different diameters were placed in tibia and femur of animals. Statins improved osseointegration and enhanced contact of implant surface with the newly formed bone, as well as significantly increased the volume of newly formed bone in lab animals. The purpose of this chapter is to prove the relationship between local use of statins and better osseointegration, as well as a larger amount of newly formed bone around the implant. Knowledge of the effect of frequently prescribed medications on dental procedures and osseointegration is necessary for both students and physicians.
Effect of Atorvastatin in radiographic density on alveolar bone loss in wistar rats
Brazilian Dental Journal, 2010
The purpose of this study was to evaluate the effect of Atorvastatin (ATV) on alveolar bone loss induced in rats. Periodontitis was induced by ligature placement around the upper second left molar in a total of 24 male Wistar rats (± 200 g). Groups of 6 animals received via oral gavage either saline or ATV (1, 3 and 9 mg/kg) during 11 days. After this time, the animals were sacrificed and their maxillae were removed, defleshed, radiographed by Digora System®, and latter stained to be photographed using a digital camera. Data were analyzed statistically by ANOVA and Bonferroni test at 5% significance level and presented as mean ± SEM. ATV (9 mg/kg) caused a significant increase on gray tone variation of over 48% (118.3 ± 12.0 gray tones) when compared to saline (79.8 ± 6.2 gray tones), indicating greater radiographic density. These data were corroborated by macroscopic findings, where ATV (9 mg/kg) reduced alveolar bone loss by over 47% (p<0.05), when compared to the group of untr...
The role of atorvastatin in bone metabolism in male albino Wistar rats
Pharmazie
Statins have been widely used for the treatment of hypercholesterolemia, and recent studies have shown that these drugs also affect bone metabolism. The aim of this experiment was to follow the effect of atorvastatin on bone metabolism in male albino Wistar rats. Our study was carried out on 16 rats (240 +/- 10g) which were randomly divided into 2 groups of 8 animals. The control group (CO) was given aqua pro injectione (0.2 mL/100 g BW; gavage) and the experimental group atorvastatin suspension (AT; 0.3 mg in 0.2 mL aqua pro inj./100 g BW; gavage) daily for 8 weeks. We examined serum markers of bone turnover using ELISA - C-terminal crosslinking telopeptide of type I collagen (CTX-I), total osteocalcin (total OC), procollagen type I N propeptide (PINP) and bone alkaline phosphatase (bone ALP). We investigated bone morphogenetic protein-2 (BMP-2) in the proximal tibia using Western blot analysis. Additionally, we measured bone mineral density (BMD). The femurs were used for a three-...
Recombinant osteoprotegerin effects during orthodontic movement in a rat model
The European Journal of Orthodontics, 2015
Background and objectives: Anchorage is one of the most challenging sides in orthodontics. The use of biological modulators that inhibit osteoclasts could be a solution to address these problems and provide new adjunctive approaches. The aim of this study was to assess the effectiveness of recombinant osteoprotegerin fusion protein (OPG-Fc) in orthodontic anchorage. Materials and methods: Two groups of male Sprague-Dawley rats were utilized. The animals in the experimental group received twice-weekly injections with high dose of OPG-Fc (5.0 mg/kg) in mesial and distal mucosa of the first molars, and those in the control group received no drugs. Right first maxillary molars were mesialized using a calibrated nickel-titanium spring connected to an anterior mini-screw. Tooth movement was measured by two blinded observers using scanned and magnified stone casts. Receptor activator of nuclear factor κB (RANK), run-related transcription factor 2 (Runx2), type I collagen, vimentin, matrix metalloproteinases 2 and 9, S100 protein and the putative mechanoproteins acid-sensing ion channel (ASIC2) and transient receptor potential vainilloid 4 (TRPV4) were evaluated using immunohistochemistry. Results: OPG-Fc group showed an important decreased in mesial molar movement with only 52%, 31%, and 22% of the total mesial molar movement compared with control group at Days 7, 14, and 21, respectively (P < 0.001). RANK ligand and Runx2 positive cells were severely reduced after OPG-Fc treatment. Periodontal ligament architecture, cell arrangement, and immunohistochemical patter for vimentin, type I collagen and the mechanoproteins TRPV4 and ASIC2 were altered by tooth movement and all these parameters altered by the applied treatment. Conclusions: OPG-Fc effectively inhibits osteoclastogenesis resulting in improved bone quantity and orthodontic anchorage. Based on present results, OPG-Fc could have clinical utility in preventing undesired tooth movements. the bone remodeling occurring after the application of mechanical forces (1). Therefore, drugs influencing bony cells biology, may affect the results of orthodontic treatment (2), as it has been shown
Atorvastatin, a double weapon in osteoporosis treatment: an experimental and clinical study
Drug Design Development and Therapy, 2017
The aim of this study was to evaluate the effect of atorvastatin on the bone formation and resorption markers in ovariectomized rats (experimental study), and to study its effect on the bone mineral density (BMD) in postmenopausal osteoporotic women (clinical study). Materials and methods: The study involved experimental and clinical aspects. In the experimental aspect, 42 female Wistar rats were divided into five groups: Group I (n=6; sham-operated), Group II (n=6; 1 mL of carboxymethyl cellulose [CMC] was administered orally), Group III (n=6; 20 mg/kg orally of atorvastatin was administered), Group IV (n=12; untreated ovariectomized [OVX] rats and served as a model of osteoporosis [OP]) and Group V (n=12; 20 mg/kg orally of atorvastatin was administered to ovariectomized rats). After 4 weeks, serum acid phosphatase, alkaline phosphatase, osteocalcin, total calcium and inorganic phosphorus were assessed. Then, 3 µm thickness lumbar and femur sections were examined using a light microscope to assess cortical thickness, trabecular area, numbers of osteoblasts and osteoclasts. In the clinical aspect, 85 post-menopausal osteoporotic females with recently detected hyperlipidemia participated in the study. Atorvastatin 40 mg/day, calcium carbonate 500 mg/day and vitamin D 800 international units were given to all patients for a period of 18 months. BMD was measured at the start and at the end of the study by dual-energy X-ray absorptiometry (DEXA). Results: In the experiment aspect, the biomarkers of bone remodeling were notably elevated in the OVX group. Administration of atorvastatin produced a significant decrease in the level of these bone metabolic markers. Atorvastatin significantly ameliorates osteoporotic changes induced by ovariectomy. In the clinical aspect, after 18 months the DEXA showed improvement in the T-score for the three measured zones; however, these changes were statistically significant only in the femoral neck area. Conclusion: Atorvastatin was able to decrease the rate of bone metabolism and increase osteogenic activity. It has dual mode of action; both anabolic and antiresorptive effect on bone. This lipophilic statin member may act as a double weapon drug.
The rate and the type of orthodontic tooth movement is influenced by bone turnover in a rat model
The European Journal of Orthodontics, 2000
The influence of bone metabolism on both the rate and the type of orthodontic tooth movement was investigated. A rat model in which high (n = 16) and low (n = 17) bone turnover was pharmacologically induced was used. A non-pharmacologically treated group (n = 19) served as the control. A mesially directed constant single force of 25 cN was applied to the upper left first molar for a period of 3 weeks. The study was performed as a splitmouth design, the contralateral side of each animal serving as its control. The displacement of the molar crown was measured with an electronic calliper, while changes in inclination of the teeth were measured from micro-CT scans of the excised maxillae. The bone turnover significantly affected the rate of tooth movement. In the case of high turnover, the rate of tooth movement was increased while it was reduced in the case of low turnover. A controlled mesial tipping in all three groups was observed, but the actual location of the centre of rotation seemed to be influenced by the metabolic state of the bone. Based on the results it can be concluded that deviations in bone turnover influence the response to orthodontic forces, and should be taken into consideration when planning orthodontic treatment in patients with metabolic bone disease or those on chronic medication influencing bone metabolism.
Running title: Statins and relapse after orthodontic treatment
2021
1. Masoomeh Ghasemi 1 Assistant Professor of Pediatrics and faculty member of MedicineSchool, Bam University of Medical Sciences, Bam, Iran. 2. Mansour Arab 2 Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran. 3. Maryam Askary Zadeh Mahani * Faculty Member and PhD Student of Nursing. Kerman University of Medical Sciences. Kerman, Iran. 4. Fatemeh Yazdanpanah 4 Assistant Professor of Psychiatryand faculty member of Medicine School, Bam University of Medical Sciences, Bam, Iran. 5. Shima Arab 5 Member of Student Research Committee of Bam University of Medical Sciences, Bam, Iran. 6. Ali Arab 6 Member of Student Research Committee of School of Nursing, Yazd University of Medical Sciences, Yazd, Iran. 7. Poria Hoseini Aliabadi Member of Student Research Committee of School of Medicine, Bam University of Medical Sciences, Bam, Iran. orcid.org/0000-0002-3001-2948
SciDoc Publishers, 2021
In orthodontics, anchorage is prevention of unwanted tooth movement. Anchorage has an important role in the orthodontic treatment of almost all types of malocclusions. Good anchorage control helps to achieve excellent treatment results. It means that there is a minimal or no movement of the anchorage unit during the orthodontic treatment. The movement of the anchorage unit can be related to the Newton’s Third Law of Motion, where every action has an equal and opposite reaction. Here, the movement of the desired teeth is the “action”, whereas movement of the anchorage unit is the “reaction” [1]. Various methods have been designed to enhance the anchorage control, namely, headgears, transpalatal arch, Nance palatal arch, lingual stabilizing arch, intermaxillary elastics, miniscrews, mini-plates, mini-implants, pharmacological agents etc.